<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://stocktwits.com/sitemap/rss_feed.xml</title><link>https://stocktwits.com/sitemap/rss_feed.xml</link><description>Individual feed output.</description><lastBuildDate>Mon, 02 Feb 2026 17:07:38 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Boeing, GE May Need To Redesign Engine Seal On 777X Jetliner: Report</title><link>https://stocktwits.com/news-articles/markets/equity/boeing-ge-may-need-to-redesign-engine-seal-on-777x-jetliner-report/cZbgzZ8R4kw</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>According to a report from Bloomberg news, which cited people familiar with the matter, a seal on the engine of the planemaker’s aircraft may have pot...</description><pubDate>Mon, 02 Feb 2026 21:12:37 GMT</pubDate></item><item><title>MarineMax Shares Rally On Reported Buyout Offer: Here Are The Details</title><link>https://stocktwits.com/news-articles/markets/equity/marinemax-shares-rally-on-reported-buyout-offer/cZbgz1bR4kv</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Reuters reported on Monday, citing people familiar with the matter, that Donerail has offered $35 per share in cash for MarineMax.</description><pubDate>Mon, 02 Feb 2026 21:08:25 GMT</pubDate></item><item><title>Immunitybio Initiates Another Cell Therapy Trial With No Chemotherapy Needs</title><link>https://stocktwits.com/news-articles/markets/equity/immunitybio-initiates-another-cell-therapy-trial-with-no-chemotherapy-needs/cZbgyGgR4kH</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>The company said that outpatient study will evaluate ImmunityBio’s novel, off-the-shelf cell therapy CD19 CAR-NK in combination with its other drug An...</description><pubDate>Mon, 02 Feb 2026 20:51:43 GMT</pubDate></item><item><title>Snap Shares Are Tumbling Today As Focus Turns To Q4 Earnings – What Are Investors Expecting?</title><link>https://stocktwits.com/news-articles/markets/equity/snap-shares-are-tumbling-today-as-focus-shifts-to-earnings/cZbgUUKR4ku</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>The Wall Street expects the company to post a profit of $0.15 per share, almost flat from the same year-ago quarter.</description><pubDate>Mon, 02 Feb 2026 20:48:39 GMT</pubDate></item><item><title>C1 Fund (NYSE: CFND) Announces First Portfolio Company Exit Within Six Months After Fund IPO</title><link>https://stocktwits.com/news-articles/business/others/c1-fund-nyse-cfnd-announces-first-portfolio-company-exit-within-six-months-after-fund-ipo/cZbgUWYR4kM</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description></description><pubDate>Mon, 02 Feb 2026 20:28:07 GMT</pubDate></item></channel></rss>